These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Recommendations on the diagnosis and treatment of anti-neutrophil cytoplasmic antibody associated vasculitis in China]. Tian XP; Zhao LK; Jiang ZY; Wang Y; Huang CB; Zhao Y Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1128-1135. PubMed ID: 36207967 [TBL] [Abstract][Full Text] [Related]
24. Respiratory involvement in antineutrophil cytoplasmic antibody-associated vasculitides: a retrospective study based on POLVAS registry. Biedroń G; Włudarczyk A; Wawrzycka-Adamczyk K; Wójcik K; Musiał J; Bazan-Socha S; Zdrojewski Z; Masiak A; Czuszyńska Z; Majdan M; Jeleniewicz R; Klinger M; Krajewska M; Augustyniak-Bartosik H; Jakuszko K; Brzosko M; Brzosko I; Dębska-Ślizień A; Storoniak H; Bułło-Piontecka B; Tłustochowicz W; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ; Szczeklik W Clin Exp Rheumatol; 2022 May; 40(4):720-726. PubMed ID: 35485410 [TBL] [Abstract][Full Text] [Related]
25. Impact of renal involvement on survival in ANCA-associated vasculitis. Rathi M; Pinto B; Dhooria A; Sagar V; Mittal T; Rajan R; Dhir V; Kumar S; Sharma K; Nada R; Singh S; Minz RW; Sharma A Int Urol Nephrol; 2016 Sep; 48(9):1477-82. PubMed ID: 27272254 [TBL] [Abstract][Full Text] [Related]
26. An update on dıagnosıs and treatment of ANCA assocıated renal vasculıtıs. Turkmen K; Ozer H; Tesar V Int Urol Nephrol; 2023 Nov; 55(11):2817-2827. PubMed ID: 37010734 [TBL] [Abstract][Full Text] [Related]
27. Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway. Nilsen AT; Karlsen C; Bakland G; Watts R; Luqmani R; Koldingsnes W Rheumatology (Oxford); 2020 Sep; 59(9):2316-2324. PubMed ID: 31859355 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis. Yamada Y; Harada M; Hara Y; Iwabuchi R; Hashimoto K; Yamamoto S; Kamijo Y Arthritis Res Ther; 2021 Jan; 23(1):28. PubMed ID: 33446268 [TBL] [Abstract][Full Text] [Related]
29. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis. Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364 [TBL] [Abstract][Full Text] [Related]
30. Eosinophilic granulomatosis with polyangiitis. Villa-Forte A Postgrad Med; 2023 Jan; 135(sup1):52-60. PubMed ID: 36259957 [TBL] [Abstract][Full Text] [Related]
32. Pulmonary manifestations and outcomes in paediatric ANCA-associated vasculitis: a single-centre experience. Sayad E; Vogel TP; Guillerman RP; Spielberg D; McNeill DM; De Guzman M; Orman G; Silva-Carmona M Rheumatology (Oxford); 2021 Jul; 60(7):3199-3208. PubMed ID: 33355338 [TBL] [Abstract][Full Text] [Related]
33. Demographic and Clinical Features of ANCA-Associated Vasculitides in a Peruvian Tertiary Center. Pimentel-Quiroz VR; Sánchez-Torres A; Acevedo-Vásquez E; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Medina-Chinchón M; Zevallos F; Noriega-Zapata E; Alfaro-Lozano J; Cucho-Venegas JM; Sánchez-Schwartz C; Rodríguez-Bellido Z; Perich-Campos R; Pastor-Asurza CA; Alarcón GS; Ugarte-Gil MF J Clin Rheumatol; 2021 Sep; 27(6S):S246-S251. PubMed ID: 33044385 [TBL] [Abstract][Full Text] [Related]
34. Common clinical pattern of antineutrophil cytoplasmic antibody -associated vasculitis: An experience from a multicenter study in Saudi Arabia. Alfuwayris JJ; Almulhim AM; Almansour MA; Albadi MA; Alhomood IA; Alblewi F; Althemery AU Saudi Med J; 2023 May; 44(5):486-491. PubMed ID: 37182925 [TBL] [Abstract][Full Text] [Related]